Skip to main content
Top
Published in: Diabetologia 2/2010

01-02-2010 | Article

Peroxisome proliferator-activated receptor α (PPARα) protects against oleate-induced INS-1E beta cell dysfunction by preserving carbohydrate metabolism

Authors: F. Frigerio, T. Brun, C. Bartley, A. Usardi, D. Bosco, K. Ravnskjær, S. Mandrup, P. Maechler

Published in: Diabetologia | Issue 2/2010

Login to get access

Abstract

Aims/hypothesis

Pancreatic beta cells chronically exposed to fatty acids may lose specific functions and even undergo apoptosis. Generally, lipotoxicity is triggered by saturated fatty acids, whereas unsaturated fatty acids induce lipodysfunction, the latter being characterised by elevated basal insulin release and impaired glucose responses. The peroxisome proliferator-activated receptor α (PPARα) has been proposed to play a protective role in this process, although the cellular mechanisms involved are unclear.

Methods

We modulated PPARα production in INS-1E beta cells and investigated key metabolic pathways and genes responsible for metabolism–secretion coupling during a culture period of 3 days in the presence of 0.4 mmol/l oleate.

Results

In INS-1E cells, the secretory dysfunction primarily induced by oleate was aggravated by silencing of PPARα. Conversely, PPARα upregulation preserved glucose-stimulated insulin secretion, essentially by increasing the response at a stimulatory concentration of glucose (15 mmol/l), a protection we also observed in human islets. The protective effect was associated with restored glucose oxidation rate and upregulation of the anaplerotic enzyme pyruvate carboxylase. PPARα overproduction increased both β-oxidation and fatty acid storage in the form of neutral triacylglycerol, revealing overall induction of lipid metabolism. These observations were substantiated by expression levels of associated genes.

Conclusions/interpretation

PPARα protected INS-1E beta cells from oleate-induced dysfunction, promoting both preservation of glucose metabolic pathways and fatty acid turnover.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kadowaki T, Hara K, Yamauchi T, Terauchi Y, Tobe K, Nagai R (2003) Molecular mechanism of insulin resistance and obesity. Exp Biol Med (Maywood) 228:1111–1117 Kadowaki T, Hara K, Yamauchi T, Terauchi Y, Tobe K, Nagai R (2003) Molecular mechanism of insulin resistance and obesity. Exp Biol Med (Maywood) 228:1111–1117
2.
3.
go back to reference Unger RH, Zhou YT (2001) Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 50(Suppl 1):S118–S121CrossRefPubMed Unger RH, Zhou YT (2001) Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 50(Suppl 1):S118–S121CrossRefPubMed
4.
go back to reference Maassen JA, ’t Hart LM, Janssen GM, Reiling E, Romijn JA, Lemkes HH (2006) Mitochondrial diabetes and its lessons for common type 2 diabetes. Biochem Soc Trans 34:819–823CrossRefPubMed Maassen JA, ’t Hart LM, Janssen GM, Reiling E, Romijn JA, Lemkes HH (2006) Mitochondrial diabetes and its lessons for common type 2 diabetes. Biochem Soc Trans 34:819–823CrossRefPubMed
5.
go back to reference Prentki M, Nolan CJ (2006) Islet beta cell failure in type 2 diabetes. J Clin Invest 116:1802–1812CrossRefPubMed Prentki M, Nolan CJ (2006) Islet beta cell failure in type 2 diabetes. J Clin Invest 116:1802–1812CrossRefPubMed
6.
go back to reference Zhou YP, Grill VE (1994) Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93:870–876CrossRefPubMed Zhou YP, Grill VE (1994) Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93:870–876CrossRefPubMed
7.
8.
go back to reference Leone TC, Weinheimer CJ, Kelly DP (1999) A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A 96:7473–7478CrossRefPubMed Leone TC, Weinheimer CJ, Kelly DP (1999) A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A 96:7473–7478CrossRefPubMed
9.
go back to reference Patsouris D, Reddy JK, Muller M, Kersten S (2006) Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression. Endocrinology 147:1508–1516CrossRefPubMed Patsouris D, Reddy JK, Muller M, Kersten S (2006) Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression. Endocrinology 147:1508–1516CrossRefPubMed
10.
go back to reference Chakravarthy MV, Pan Z, Zhu Y et al (2005) ‘New’ hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab 1:309–322CrossRefPubMed Chakravarthy MV, Pan Z, Zhu Y et al (2005) ‘New’ hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab 1:309–322CrossRefPubMed
11.
go back to reference Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W (1999) Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 103:1489–1498CrossRefPubMed Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W (1999) Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 103:1489–1498CrossRefPubMed
12.
go back to reference Sugden MC, Holness MJ (2008) Role of nuclear receptors in the modulation of insulin secretion in lipid-induced insulin resistance. Biochem Soc Trans 36:891–900CrossRefPubMed Sugden MC, Holness MJ (2008) Role of nuclear receptors in the modulation of insulin secretion in lipid-induced insulin resistance. Biochem Soc Trans 36:891–900CrossRefPubMed
13.
go back to reference Gremlich S, Nolan C, Roduit R et al (2005) Pancreatic islet adaptation to fasting is dependent on peroxisome proliferator-activated receptor alpha transcriptional up-regulation of fatty acid oxidation. Endocrinology 146:375–382CrossRefPubMed Gremlich S, Nolan C, Roduit R et al (2005) Pancreatic islet adaptation to fasting is dependent on peroxisome proliferator-activated receptor alpha transcriptional up-regulation of fatty acid oxidation. Endocrinology 146:375–382CrossRefPubMed
14.
go back to reference Zhou YT, Shimabukuro M, Wang MY et al (1998) Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells. Proc Natl Acad Sci U S A 95:8898–8903CrossRefPubMed Zhou YT, Shimabukuro M, Wang MY et al (1998) Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells. Proc Natl Acad Sci U S A 95:8898–8903CrossRefPubMed
15.
go back to reference Ravnskjaer K, Boergesen M, Rubi B et al (2005) Peroxisome proliferator-activated receptor alpha (PPARalpha) potentiates, whereas PPARgamma attenuates, glucose-stimulated insulin secretion in pancreatic beta-cells. Endocrinology 146:3266–3276CrossRefPubMed Ravnskjaer K, Boergesen M, Rubi B et al (2005) Peroxisome proliferator-activated receptor alpha (PPARalpha) potentiates, whereas PPARgamma attenuates, glucose-stimulated insulin secretion in pancreatic beta-cells. Endocrinology 146:3266–3276CrossRefPubMed
16.
go back to reference El-Assaad W, Buteau J, Peyot ML et al (2003) Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology 144:4154–4163CrossRefPubMed El-Assaad W, Buteau J, Peyot ML et al (2003) Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology 144:4154–4163CrossRefPubMed
17.
go back to reference Roche E, Buteau J, Aniento I, Reig JA, Soria B, Prentki M (1999) Palmitate and oleate induce the immediate-early response genes c-fos and nur-77 in the pancreatic beta-cell line INS-1. Diabetes 48:2007–2014CrossRefPubMed Roche E, Buteau J, Aniento I, Reig JA, Soria B, Prentki M (1999) Palmitate and oleate induce the immediate-early response genes c-fos and nur-77 in the pancreatic beta-cell line INS-1. Diabetes 48:2007–2014CrossRefPubMed
18.
go back to reference Maedler K, Spinas GA, Dyntar D, Moritz W, Kaiser N, Donath MY (2001) Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes 50:69–76CrossRefPubMed Maedler K, Spinas GA, Dyntar D, Moritz W, Kaiser N, Donath MY (2001) Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes 50:69–76CrossRefPubMed
19.
go back to reference Brun T, Assimacopoulos-Jeannet F, Corkey BE, Prentki M (1997) Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic beta-cell line INS-1. Diabetes 46:393–400CrossRefPubMed Brun T, Assimacopoulos-Jeannet F, Corkey BE, Prentki M (1997) Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic beta-cell line INS-1. Diabetes 46:393–400CrossRefPubMed
20.
go back to reference Frigerio F, Chaffard G, Berwaer M, Maechler P (2006) The antiepileptic drug topiramate preserves metabolism-secretion coupling in insulin secreting cells chronically exposed to the fatty acid oleate. Biochem Pharmacol 72:965–973CrossRefPubMed Frigerio F, Chaffard G, Berwaer M, Maechler P (2006) The antiepileptic drug topiramate preserves metabolism-secretion coupling in insulin secreting cells chronically exposed to the fatty acid oleate. Biochem Pharmacol 72:965–973CrossRefPubMed
21.
go back to reference Lalloyer F, Vandewalle B, Percevault F et al (2006) Peroxisome proliferator-activated receptor alpha improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets. Diabetes 55:1605–1613CrossRefPubMed Lalloyer F, Vandewalle B, Percevault F et al (2006) Peroxisome proliferator-activated receptor alpha improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets. Diabetes 55:1605–1613CrossRefPubMed
22.
go back to reference Bergeron R, Yao J, Woods JW et al (2006) Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: a comparison with PPAR gamma agonism. Endocrinology 147:4252–4262CrossRefPubMed Bergeron R, Yao J, Woods JW et al (2006) Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: a comparison with PPAR gamma agonism. Endocrinology 147:4252–4262CrossRefPubMed
23.
go back to reference Holness MJ, Smith ND, Greenwood GK, Sugden MC (2003) Acute (24 h) activation of peroxisome proliferator-activated receptor-alpha (PPARalpha) reverses high-fat feeding-induced insulin hypersecretion in vivo and in perifused pancreatic islets. J Endocrinol 177:197–205CrossRefPubMed Holness MJ, Smith ND, Greenwood GK, Sugden MC (2003) Acute (24 h) activation of peroxisome proliferator-activated receptor-alpha (PPARalpha) reverses high-fat feeding-induced insulin hypersecretion in vivo and in perifused pancreatic islets. J Endocrinol 177:197–205CrossRefPubMed
24.
go back to reference Holness MJ, Smith ND, Greenwood GK, Sugden MC (2007) PPARalpha activation reverses adverse effects induced by high-saturated-fat feeding on pancreatic beta-cell function in late pregnancy. Am J Physiol Endocrinol Metab 292:E1087–E1094CrossRefPubMed Holness MJ, Smith ND, Greenwood GK, Sugden MC (2007) PPARalpha activation reverses adverse effects induced by high-saturated-fat feeding on pancreatic beta-cell function in late pregnancy. Am J Physiol Endocrinol Metab 292:E1087–E1094CrossRefPubMed
25.
go back to reference Merglen A, Theander S, Rubi B, Chaffard G, Wollheim CB, Maechler P (2004) Glucose sensitivity and metabolism–secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology 145:667–678CrossRefPubMed Merglen A, Theander S, Rubi B, Chaffard G, Wollheim CB, Maechler P (2004) Glucose sensitivity and metabolism–secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology 145:667–678CrossRefPubMed
26.
go back to reference Cnop M, Hannaert JC, Hoorens A, Eizirik DL, Pipeleers DG (2001) Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 50:1771–1777CrossRefPubMed Cnop M, Hannaert JC, Hoorens A, Eizirik DL, Pipeleers DG (2001) Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 50:1771–1777CrossRefPubMed
27.
go back to reference Spector AA, Fletcher JE, Ashbrook JD (1971) Analysis of long-chain free fatty acid binding to bovine serum albumin by determination of stepwise equilibrium constants. Biochemistry 10:3229–3232CrossRefPubMed Spector AA, Fletcher JE, Ashbrook JD (1971) Analysis of long-chain free fatty acid binding to bovine serum albumin by determination of stepwise equilibrium constants. Biochemistry 10:3229–3232CrossRefPubMed
28.
go back to reference Richieri GV, Kleinfeld AM (1995) Unbound free fatty acid levels in human serum. J Lipid Res 36:229–240PubMed Richieri GV, Kleinfeld AM (1995) Unbound free fatty acid levels in human serum. J Lipid Res 36:229–240PubMed
29.
go back to reference Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497–509PubMed Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497–509PubMed
30.
go back to reference de Andrade PB, Rubi B, Frigerio F, van den Ouweland JM, Maassen JA, Maechler P (2006) Diabetes-associated mitochondrial DNA mutation A3243G impairs cellular metabolic pathways necessary for beta cell function. Diabetologia 49:1816–1826CrossRefPubMed de Andrade PB, Rubi B, Frigerio F, van den Ouweland JM, Maassen JA, Maechler P (2006) Diabetes-associated mitochondrial DNA mutation A3243G impairs cellular metabolic pathways necessary for beta cell function. Diabetologia 49:1816–1826CrossRefPubMed
31.
go back to reference Praul CA, Brubaker KD, Leach RM, Gay CV (1998) Detection of endogenous biotin-containing proteins in bone and cartilage cells with streptavidin systems. Biochem Biophys Res Commun 247:312–314CrossRefPubMed Praul CA, Brubaker KD, Leach RM, Gay CV (1998) Detection of endogenous biotin-containing proteins in bone and cartilage cells with streptavidin systems. Biochem Biophys Res Commun 247:312–314CrossRefPubMed
32.
go back to reference Schuit F, de Vos A, Farfari S et al (1997) Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in beta cells. J Biol Chem 272:18572–18579CrossRefPubMed Schuit F, de Vos A, Farfari S et al (1997) Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in beta cells. J Biol Chem 272:18572–18579CrossRefPubMed
33.
go back to reference Maedler K, Oberholzer J, Bucher P, Spinas GA, Donath MY (2003) Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes 52:726–733CrossRefPubMed Maedler K, Oberholzer J, Bucher P, Spinas GA, Donath MY (2003) Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes 52:726–733CrossRefPubMed
34.
go back to reference Laybutt DR, Sharma A, Sgroi DC, Gaudet J, Bonner-Weir S, Weir GC (2002) Genetic regulation of metabolic pathways in beta-cells disrupted by hyperglycemia. J Biol Chem 277:10912–10921CrossRefPubMed Laybutt DR, Sharma A, Sgroi DC, Gaudet J, Bonner-Weir S, Weir GC (2002) Genetic regulation of metabolic pathways in beta-cells disrupted by hyperglycemia. J Biol Chem 277:10912–10921CrossRefPubMed
35.
go back to reference Dillon JS, Yaney GC, Zhou Y et al (2000) Dehydroepiandrosterone sulfate and beta-cell function: enhanced glucose-induced insulin secretion and altered gene expression in rodent pancreatic beta-cells. Diabetes 49:2012–2020CrossRefPubMed Dillon JS, Yaney GC, Zhou Y et al (2000) Dehydroepiandrosterone sulfate and beta-cell function: enhanced glucose-induced insulin secretion and altered gene expression in rodent pancreatic beta-cells. Diabetes 49:2012–2020CrossRefPubMed
36.
go back to reference Yoshikawa H, Tajiri Y, Sako Y, Hashimoto T, Umeda F, Nawata H (2001) Effects of bezafibrate on beta-cell function of rat pancreatic islets. Eur J Pharmacol 426:201–206CrossRefPubMed Yoshikawa H, Tajiri Y, Sako Y, Hashimoto T, Umeda F, Nawata H (2001) Effects of bezafibrate on beta-cell function of rat pancreatic islets. Eur J Pharmacol 426:201–206CrossRefPubMed
37.
go back to reference Terauchi Y, Kadowaki T (2005) Peroxisome proliferator-activated receptors and insulin secretion. Endocrinology 146:3263–3265CrossRefPubMed Terauchi Y, Kadowaki T (2005) Peroxisome proliferator-activated receptors and insulin secretion. Endocrinology 146:3263–3265CrossRefPubMed
38.
go back to reference Tordjman K, Standley KN, Bernal-Mizrachi C et al (2002) PPARalpha suppresses insulin secretion and induces UCP2 in insulinoma cells. J Lipid Res 43:936–943PubMed Tordjman K, Standley KN, Bernal-Mizrachi C et al (2002) PPARalpha suppresses insulin secretion and induces UCP2 in insulinoma cells. J Lipid Res 43:936–943PubMed
39.
go back to reference Renner ED, Bernlohr RW (1972) Characterization and regulation of pyruvate carboxylase of Bacillus licheniformis. J Bacteriol 109:764–772PubMed Renner ED, Bernlohr RW (1972) Characterization and regulation of pyruvate carboxylase of Bacillus licheniformis. J Bacteriol 109:764–772PubMed
40.
go back to reference Satapati S, He T, Inagaki T et al (2008) Partial resistance to peroxisome proliferator-activated receptor-alpha agonists in ZDF rats is associated with defective hepatic mitochondrial metabolism. Diabetes 57:2012–2021CrossRefPubMed Satapati S, He T, Inagaki T et al (2008) Partial resistance to peroxisome proliferator-activated receptor-alpha agonists in ZDF rats is associated with defective hepatic mitochondrial metabolism. Diabetes 57:2012–2021CrossRefPubMed
41.
go back to reference Munday MR, Hemingway CJ (1999) The regulation of acetyl-CoA carboxylase—a potential target for the action of hypolipidemic agents. Adv Enzyme Regul 39:205–234CrossRefPubMed Munday MR, Hemingway CJ (1999) The regulation of acetyl-CoA carboxylase—a potential target for the action of hypolipidemic agents. Adv Enzyme Regul 39:205–234CrossRefPubMed
42.
go back to reference Sun Y, Ren M, Gao GQ et al (2008) Chronic palmitate exposure inhibits AMPKalpha and decreases glucose-stimulated insulin secretion from beta-cells: modulation by fenofibrate. Acta Pharmacol Sin 29:443–450CrossRefPubMed Sun Y, Ren M, Gao GQ et al (2008) Chronic palmitate exposure inhibits AMPKalpha and decreases glucose-stimulated insulin secretion from beta-cells: modulation by fenofibrate. Acta Pharmacol Sin 29:443–450CrossRefPubMed
43.
go back to reference Listenberger LL, Han X, Lewis SE et al (2003) Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A 100:3077–3082CrossRefPubMed Listenberger LL, Han X, Lewis SE et al (2003) Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A 100:3077–3082CrossRefPubMed
44.
go back to reference Coll T, Eyre E, Rodriguez-Calvo R et al (2008) Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells. J Biol Chem 283:11107–11116CrossRefPubMed Coll T, Eyre E, Rodriguez-Calvo R et al (2008) Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells. J Biol Chem 283:11107–11116CrossRefPubMed
Metadata
Title
Peroxisome proliferator-activated receptor α (PPARα) protects against oleate-induced INS-1E beta cell dysfunction by preserving carbohydrate metabolism
Authors
F. Frigerio
T. Brun
C. Bartley
A. Usardi
D. Bosco
K. Ravnskjær
S. Mandrup
P. Maechler
Publication date
01-02-2010
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 2/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1590-6

Other articles of this Issue 2/2010

Diabetologia 2/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.